The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape

Future Oncology Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2rAWhMl
via IFTTT